WebApr 11, 2024 · Citius Pharmaceuticals - CTXR Stock Forecast, Price & News $1.34 +0.17 (+14.53%) (As of 04/3/2024 04:00 PM ET) Compare Today's Range $1.17 $1.38 50-Day Range $0.98 $1.42 52-Week Range $0.77 $2.01 Volume 1.81 million shs Average Volume 843,413 shs Market Capitalization $195.99 million P/E Ratio N/A Dividend Yield … WebCTXR 15Min Scalper's edition test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives …
Headlines for Citius Pharmaceuticals Inc. (NAS:CTXR)
WebJul 1, 2024 · Shares of Citius Pharmaceuticals ( CTXR -0.99%), a clinical-stage biopharmaceutical company, are getting beaten down today after the company released disappointing news regarding its lead... WebJD.com stock price target cut to $45 from $62 at Susquehanna. Mar. 13, 2024 at 6:41 a.m. ET by Tomi Kilgore. how delta-sigma adcs work part
SRGA Stock Price Surgalign Holdings Inc. Stock Quote (U.S.: …
WebCTXR - Citius Pharmaceuticals Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. WebApr 10, 2024 · TSOI Complete Therapeutic Solutions International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebMar 24, 2024 · Earnings for Citius Pharmaceuticals are expected to grow in the coming year, from ($0.11) to $0.96 per share. Citius Pharmaceuticals has not formally confirmed its … how deli meat is made